KR19990087363A - 사람 또는 수의학용 항진균 활성을 갖는 아졸 화합물 - Google Patents

사람 또는 수의학용 항진균 활성을 갖는 아졸 화합물 Download PDF

Info

Publication number
KR19990087363A
KR19990087363A KR1019980706773A KR19980706773A KR19990087363A KR 19990087363 A KR19990087363 A KR 19990087363A KR 1019980706773 A KR1019980706773 A KR 1019980706773A KR 19980706773 A KR19980706773 A KR 19980706773A KR 19990087363 A KR19990087363 A KR 19990087363A
Authority
KR
South Korea
Prior art keywords
formula
compounds
chloro
hydrogen
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019980706773A
Other languages
English (en)
Korean (ko)
Inventor
마우로 나폴레타노
크리스티나 프레이레
엔리코 알비니
기오바나 스키오파카시
Original Assignee
스테파노 파노시안
잠본 그룹 에스. 피. 에이.
지오르기오 바실레
이사그로 에스.피.에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스테파노 파노시안, 잠본 그룹 에스. 피. 에이., 지오르기오 바실레, 이사그로 에스.피.에이 filed Critical 스테파노 파노시안
Publication of KR19990087363A publication Critical patent/KR19990087363A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Devices For Medical Bathing And Washing (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1019980706773A 1996-02-28 1997-02-25 사람 또는 수의학용 항진균 활성을 갖는 아졸 화합물 Ceased KR19990087363A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT96MI000371A IT1283038B1 (it) 1996-02-28 1996-02-28 Composti azolici ad attivita' antimicotica per uso umano e veterinario
ITMI96000371 1996-02-28
PCT/EP1997/000886 WO1997031903A1 (en) 1996-02-28 1997-02-25 Azole compounds endowed with antimycotic activity for human and veterinary use

Publications (1)

Publication Number Publication Date
KR19990087363A true KR19990087363A (ko) 1999-12-27

Family

ID=11373418

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980706773A Ceased KR19990087363A (ko) 1996-02-28 1997-02-25 사람 또는 수의학용 항진균 활성을 갖는 아졸 화합물

Country Status (32)

Country Link
US (2) US5869512A (cg-RX-API-DMAC7.html)
EP (1) EP0877739B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000505466A (cg-RX-API-DMAC7.html)
KR (1) KR19990087363A (cg-RX-API-DMAC7.html)
CN (1) CN1082050C (cg-RX-API-DMAC7.html)
AP (1) AP9801328A0 (cg-RX-API-DMAC7.html)
AT (1) ATE219066T1 (cg-RX-API-DMAC7.html)
AU (1) AU713049B2 (cg-RX-API-DMAC7.html)
BG (1) BG102711A (cg-RX-API-DMAC7.html)
BR (1) BR9707773A (cg-RX-API-DMAC7.html)
CA (1) CA2247390A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ291790B6 (cg-RX-API-DMAC7.html)
DE (1) DE69713276T2 (cg-RX-API-DMAC7.html)
DK (1) DK0877739T3 (cg-RX-API-DMAC7.html)
EA (1) EA003189B1 (cg-RX-API-DMAC7.html)
EE (1) EE03684B1 (cg-RX-API-DMAC7.html)
ES (1) ES2176689T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20002091B (cg-RX-API-DMAC7.html)
HU (1) HUP9900569A3 (cg-RX-API-DMAC7.html)
IL (1) IL125701A (cg-RX-API-DMAC7.html)
IT (1) IT1283038B1 (cg-RX-API-DMAC7.html)
NO (1) NO983953L (cg-RX-API-DMAC7.html)
NZ (1) NZ331919A (cg-RX-API-DMAC7.html)
OA (1) OA10847A (cg-RX-API-DMAC7.html)
PL (1) PL328582A1 (cg-RX-API-DMAC7.html)
PT (1) PT877739E (cg-RX-API-DMAC7.html)
SI (1) SI0877739T1 (cg-RX-API-DMAC7.html)
SK (1) SK283391B6 (cg-RX-API-DMAC7.html)
TR (1) TR199801688T2 (cg-RX-API-DMAC7.html)
UA (1) UA55405C2 (cg-RX-API-DMAC7.html)
WO (1) WO1997031903A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA971665B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296925B1 (it) * 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US6297115B1 (en) * 1998-11-06 2001-10-02 Advanced Micro Devices, Inc. Cmos processs with low thermal budget
CN1630646A (zh) * 2002-02-15 2005-06-22 三井化学株式会社 旋光性吡咯衍生物及其制造方法
GB0222964D0 (en) 2002-10-03 2002-11-13 Unilever Plc Polymeric film for water soluble package
JP7396990B2 (ja) 2017-11-27 2023-12-12 ダイナテック システムズ,インコーポレイテッド 材料除去製造品、アセンブリ、および組み立ての方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162540A (en) * 1980-12-24 1984-02-21 Ikutaro Saji Imidazolylpropanol compounds and their acid addition salts, and production and use thereof
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
EP0086304B1 (en) * 1982-02-03 1986-07-02 Imperial Chemical Industries Plc Heterocyclic compounds useful as pesticides and processes for making them
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
AU572889B2 (en) * 1983-09-26 1988-05-19 Sumitomo Chemical Company, Limited 1,2,4 - triazolyl propanols
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
IT1198240B (it) * 1986-12-23 1988-12-21 Agrimont Spa Azolilderivati fungicidi
IT1232943B (it) * 1987-11-09 1992-03-10 Mini Ricerca Scient Tecnolog Azolilderivati fungicidi.
US5134152A (en) * 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
CA2031892C (en) * 1989-12-25 2000-08-01 Minoru Tokizawa Triazole derivatives
IE912990A1 (en) * 1990-08-26 1992-03-11 Sankyo Co Anti-fungal triazole derivatives, their preparation and¹uses
GB9307924D0 (en) * 1993-04-16 1993-06-02 Zeneca Ltd Chrial synthesis
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
IT1273509B (it) * 1995-04-07 1997-07-08 Zambon Spa Composti azolici ad attivita' antimicotica per uso umano e veterinario

Also Published As

Publication number Publication date
DE69713276T2 (de) 2003-03-06
ZA971665B (en) 1997-08-29
IL125701A0 (en) 1999-04-11
US5869512A (en) 1999-02-09
ES2176689T3 (es) 2002-12-01
AP9801328A0 (en) 1998-09-30
CN1212685A (zh) 1999-03-31
HUP9900569A1 (hu) 1999-06-28
US6103909A (en) 2000-08-15
NO983953L (no) 1998-10-26
EA003189B1 (ru) 2003-02-27
JP2000505466A (ja) 2000-05-09
OA10847A (en) 2003-02-05
SK283391B6 (sk) 2003-07-01
DE69713276D1 (de) 2002-07-18
BR9707773A (pt) 2000-01-04
CA2247390A1 (en) 1997-09-04
BG102711A (bg) 1999-04-30
SI0877739T1 (en) 2002-12-31
TR199801688T2 (xx) 1998-11-23
NZ331919A (en) 1999-04-29
EP0877739B1 (en) 2002-06-12
EE03684B1 (et) 2002-04-15
ITMI960371A0 (cg-RX-API-DMAC7.html) 1996-02-28
IL125701A (en) 2003-11-23
UA55405C2 (uk) 2003-04-15
PT877739E (pt) 2002-11-29
DK0877739T3 (da) 2002-10-07
EA199800693A1 (ru) 1999-06-24
AU713049B2 (en) 1999-11-25
EP0877739A1 (en) 1998-11-18
GEP20002091B (en) 2000-05-10
WO1997031903A1 (en) 1997-09-04
IT1283038B1 (it) 1998-04-07
CZ274898A3 (cs) 1999-01-13
NO983953D0 (no) 1998-08-27
SK116198A3 (en) 1999-02-11
CZ291790B6 (cs) 2003-05-14
EE9800261A (et) 1999-02-15
ITMI960371A1 (it) 1997-08-28
CN1082050C (zh) 2002-04-03
ATE219066T1 (de) 2002-06-15
AU2092997A (en) 1997-09-16
PL328582A1 (en) 1999-02-01
HUP9900569A3 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
US5792780A (en) Azole compounds, their production and use
EP0283992B1 (en) 4-[4-[4-[4-[[2-(2,4-Difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]-methoxy]phenyl]-1-piperazinyl]phenyl]triazolones
US4661507A (en) Antifungal S-ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols and corresponding sulfoxides and sulfones
US4505919A (en) Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
FI74465B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-pyridyl-1,3-bis(1h-1,2,4-triazol-1-yl)propanoler.
US6362206B1 (en) Azole compounds, their production and use
US6103909A (en) Azole compounds endowed with antimycotic activity for human and veterinary use
US5629332A (en) Triazole compound and use thereof
US6710049B2 (en) Azole compounds as anti-fungal agents
EP0819124B1 (en) Azole compounds with antimycotic activity for human and veterinary use
WO1991012000A1 (en) ANILINE DERIVATIVES OF α-STYRYL CARBINOLS AS ANTIFUNGAL AGENTS
US20050261330A1 (en) Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents
AU2002217365A1 (en) Azole compounds as anti-fungals agents

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19980828

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20020222

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20031222

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20040422

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20031222

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I